How Will Altria Stock Stand Up to COVID-19?
Investors are scrambling to find yield. Could Altria have just the dividend yield they are looking for? Cigarettes have been considered recession-proof, but this time things may be somewhat different.
All Work
Chris Lange
How Safe Is Northrop Grumman Stock?
While the COVID-19 pandemic is ravaging the global economy, tensions are rising, and this could prove to be fruitful for defense stocks such as Northrop Grumman.
How Much Cash Can Bio-Path Burn?
Bio-Path stock has taken a beating in the past five years. Investors obviously aren’t happy about this, and the way that management and the board of directors has handled it has been clumsy.
Is Snap Stock on the Rebound?
Although Snap stock has sold off in the wake of the coronavirus outbreak, this online chat platform may offer an investment avenue to ride out this pandemic.
Macy’s Furloughs Most of Its 125,000 of Employees
Department store operator Macy’s announced on Monday that it will furlough a “majority” of its employees as a result of ongoing concerns about the coronavirus pandemic.
Big Pharma Advances on COVID-19
24/7 Wall St. has tracked some health care companies with prospects at crafting a vaccine to deal with this novel coronavirus and where they stand now.
CarMax, Conagra Brands, Walgreens and More Major Earnings Coming This Week
We are in the earnings doldrums right now, but a few more major companies will be sharing their results soon, including Walgreens and CarMax.
What Analysts Are Saying About Lululemon Stock After Earnings
After Lululemon Athletica reported solid fiscal fourth-quarter financial results after the markets closed on Thursday, analysts were fairly positive on the stock and where it can go from here.
Is a Recovery in the Cards for CannTrust Stock?
CannTrust has been one of the most beat-up marijuana stocks over the past year, but not without reason. Will the cannabis grower finally get its act together, or is this just a race to…
What Analysts Are Saying About Nike After Earnings
With its massive exposure to China and global footprint, Nike was definitely hurt by the coronavirus, but earnings demonstrated why this company is strong.
Dynavax New Vaccine: Are Investors Sick of Coronavirus Vaccine Stocks Yet?
Dynavax Technologies shares made a handy gain on Thursday after the company announced that it would be entering the coronavirus vaccine business. Is the market for these vaccines getting oversaturated?
Micron Stock Stuns Investors With Solid Q2 Results
Micron Technology reported better than expected fiscal second-quarter financial results after the markets closed on Wednesday.
Has COVID-19 Made Weight Watchers Stock Lose Enough Yet?
Also, after all this selling and the renewed focus on health, does it make the case for WW shares to shoot back up in the long term?
Will Micron Stock Lead the Recovery With Q2 Earnings?
Micron Technology is scheduled to release its fiscal second-quarter financial results after the markets close on Wednesday.
How Nike Stock Is Hurdling the Coronavirus
Nike released mixed fiscal third-quarter financial results late on Tuesday, but shares were sharply higher early Wednesday.
Major Biotechs Get Mixed Message on Short Interest
The March 13 short interest data has been compared with the previous report, and short interest moves in these selected biotech stocks were mixed.
Short Sellers Raise the Stakes in Semiconductors
The March 13 short interest data have been compared with the previous report. Short interest in most of these selected semiconductor stocks increased.
Will Semiconductor Stocks Lead the Charge to Recovery?
No industry has been safe from the market carnage due to the coronavirus pandemic. It’s uncertain if a bottom is in sight yet, but investors already are beginning to ask themselves which industries will…
What This Downgrade Means for Tesla Stock in the Near Term
Tesla was an absolute market darling going into this coronavirus scare. Since then, it has sold off with the rest of the market, and now it has been downgraded.
How Coronavirus Stocks Are Holding Up
24/7 Wall St. has tracked some health care companies with prospects at crafting a vaccine, treatment or test to deal with this coronavirus and here is where their stocks stand now.